Tag - ZetrOZ Systems

ZetrOZ Signs 5-Year Agreement With US Government to Supply Employees and Military With SAM Technology

ZetrOZ Systems has recently signed a 5-Year Healthcare Federal Supply Schedule Agreement to provide U.S. government healthcare institutes with its sustained acoustic medicine (sam®) device and hypoallergenic ultrasound coupling patches. The $3.4 million contract covers military bases and hospitals, veteran healthcare hospitals, and employees of the FBI, CIA, DOL, postal service, and other U.S. departments and agencies operating both in the United States and abroad. “We’re proud to play our part in getting and keeping our federal employees healthy […]

Sustained Acoustic Medicine Technology from ZetrOZ Systems Endorsed By American Athletes, Veterans and Workers

Professional athletes, military veterans and everyday workers are getting back in action more quickly thanks to ZetrOZ’s Sustained Acoustic Medicine (sam®) technology. In studies and testimonials, athletic trainers, veteran’s organizations, and worker health advocates credit the innovative, wearable injury healing and pain relief device for helping people regain function, while reducing the need for invasive surgery and potentially addictive pain medications. Read more >>

ZetrOZ Proudly Continues Sponsorship of Connecticut Whale Women’s Ice Hockey

ZetrOZ Systems, developer of the sam® sustained acoustic medicine device, is proud to announce its continued support of Danbury’s professional women’s ice hockey team, the Connecticut Whale of the Premier Hockey Federation. For the second consecutive year, ZetrOZ is supporting the Whale and women’s hockey with its wearable ultrasound technology that revolutionizes soft tissue injury healing. The ZetrOZ pain relief ultrasound device delivers long-duration slow-release ultrasound and promotes healing without the need for potentially addictive painkillers or invasive surgery. […]

ZetrOZ Systems Expands Patient Access for Sustained Acoustic Medicine Treatment

ZetrOZ’s sam® is the only FDA-cleared, long-duration, home-use, ultrasound treatment system, with over 30 peer-reviewed studies showing it effectively increases nutrient transport, relieves pain, restores function, and returns patients back to work, sports and other daily activities. Its continuous ultrasound therapy promotes injury healing to deep tissue by inhibiting inflammation and increasing the rate of tissue regeneration, angiogenesis, and nutrient exchange. sam® was designed for easy, long-term home use. Read more >>

FDA Created New Category for ZetrOZ’s Long-Duration Pain Management Ultrasound Device

ZetrOZ System’s Sustained Acoustic Medicine (sam®) device, the only FDA-cleared device of its kind, is part of a new category established by the U.S. Government for the novel device’s wearable, long-duration ultrasound therapy for home use. A Class II medical device initially cleared by the FDA in 2013, sam® was later provided with expanded indications in 2020. It is the only home-use, long-duration ultrasound treatment for reducing pain and improving circulation to heal soft tissue injuries. Read more >>